US awards contracts to process HALEU fuel for high-tech reactors
By Timothy Gardner
WASHINGTON, Oct 8 (Reuters) -The U.S. has awarded six companies contracts to help process a special uranium fuel meant for a new generation of reactors that could be built in coming years, the Energy Department said on Tuesday.
Russia is currently the only country that makes the high-assay low-enriched uranium fuel, or HALEU, in commercial volumes.
The companies that won the contracts and aim to de-convert HALEU are Centrus LEU.A, the U.S. division of France's state-owned nuclear fuel company Orano, GE Vernova GEV.N, BWXT BWXT.N, French firm Framatome, and Westinghouse.
Deconversion turns gaseous uranium into oxide or metal forms to be made into fuel for reactors. HALEU is uranium enriched to between 5% and 20%, which backers say has the potential to make new high-tech reactors more efficient.
Uranium fuel used in today's reactors is enriched to about 5%.
The administration of President Joe Biden believes nuclear power, which generates virtually emissions-free electricity, is critical in fighting climate change and to meet rising power demand from artificial intelligence and other consumers.
"Boosting our domestic uranium supply won’t just advance President Biden’s historic climate agenda, but also increase America’s energy security, create good-paying union jobs, and strengthen our economic competitiveness," Ali Zaidi, the national climate adviser, said in a statement.
All contracts will last for up to 10 years. Each company will get a minimum contract of $2 million, with up to $800 million available for the services, subject to the availability of appropriations, the Energy Department said.
Critics of HALEU, which has a higher fissile content, say it is a weapons risk if it gets into the wrong hands and recommend limiting its enrichment to between 10% and 12% for safety.
"This award is a critical piece of the puzzle in building an advanced nuclear fuel supply chain to support the next generation of reactors," said Amir Vexler, president and CEO of Centrus, which plans to make commercial amounts of HALEU at a plant in Ohio.
Reporting by Timothy Gardner; Editing by Sonali Paul
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
